XML 56 R12.htm IDEA: XBRL DOCUMENT v2.4.0.8
DERIVATIVE FINANCIAL INSTRUMENTS
3 Months Ended
Mar. 31, 2014
Derivative Instruments And Hedging Activities Disclosure [Abstract]  
DERIVATIVE FINANCIAL INSTRUMENTS

NOTE 5—DERIVATIVE FINANCIAL INSTRUMENTS

We enter into derivative financial instruments primarily to hedge certain firm purchase commitments and forecasted transactions denominated in foreign currencies. We record these contracts at fair value on our condensed consolidated balance sheets. Depending on the hedge designation at the inception of the contract, the related gains and losses on these contracts are either: (1) deferred as a component of AOCI until the hedged item is recognized in earnings; (2) offset against the change in fair value of the hedged firm commitment through earnings; or (3) recognized immediately in earnings. At inception and on an ongoing basis, we assess the hedging relationship to determine its effectiveness in offsetting changes in cash flows or fair value attributable to the hedged risk. We exclude from our assessment of effectiveness the portion of the fair value of the forward contracts attributable to the difference between spot exchange rates and forward exchange rates. The ineffective portion of a derivative’s change in fair value and any portion excluded from the assessment of effectiveness are immediately recognized in earnings. Gains and losses on derivative financial instruments that are immediately recognized in earnings are included as a component of gain (loss) on foreign currency-net in our condensed consolidated statements of operations.

At March 31, 2014, the majority of our foreign currency forward contracts were designated as cash flow hedging instruments. In addition, we deferred approximately $30.8 million of net losses on these derivative financial instruments in AOCI, and we expect to reclassify approximately $22.0 million of deferred losses out of AOCI by March 31, 2015, as hedged items are recognized in earnings. The notional value of our outstanding derivative contracts totaled $1.0 billion at March 31, 2014, with maturities extending through 2017. Of this amount, approximately $635.3 million is associated with various foreign currency expenditures we expect to incur on one of our Asia Pacific segment EPCI projects. These instruments consist of contracts to purchase or sell foreign-denominated currencies. At March 31, 2014, the fair value of these contracts was in a net liability position totaling $15.0 million. The fair value of outstanding derivative instruments is determined using observable financial market inputs, such as quoted market prices, and is classified as Level 2 in nature.

 

The following tables summarize our derivative financial instruments:

Asset and Liability Derivatives

 

     March 31,
2014
     December 31,
2013
 
     (Unaudited)  
     (In thousands)  

Derivatives Designated as Hedges:

     

Location

     

Accounts receivable—other

   $ 8,258       $ 11,641   

Other assets

     964         1,647   
  

 

 

    

 

 

 

Total asset derivatives

   $ 9,222       $ 13,288   
  

 

 

    

 

 

 

Accounts payable

   $ 11,781       $ 20,209   

Other liabilities

     12,436         21,846   
  

 

 

    

 

 

 

Total liability derivatives

   $ 24,217       $ 42,055   
  

 

 

    

 

 

 

The Effects of Derivative Instruments on our Financial Statements

 

     Three Months Ended
March 31,
 
     2014     2013  
     (Unaudited)  
     (In thousands)  

Derivatives Designated as Hedges:

    

Amount of gain/ (loss) recognized in other comprehensive income

   $ 12,358      $ (15,450

Income reclassified from AOCI into income: effective portion

    

Location

    

Cost of operations

   $ 202      $ 2,014   

Gain (loss) recognized in income: ineffective portion and amount excluded from effectiveness testing

    

Location

    

Gain (loss) on foreign currency—net

   $ (847   $ (2,849